Next week, UK College of Medicine and the Department of Chemistry in the UK College of Arts and Sciences will host renowned biochemist Dr. Rafael Radi for two special events on campus.
UK recently received $3 million from the National Institute on Drug Abuse and National Institute on General Medical Sciences to fund new opioid-related research in the criminal justice system.
Researchers at UK's College of Medicine have found that a class of antibiotics could be promising treatment for a form of dementia. Results of their proof of concept study were recently published in the journal Human Molecular Genetics.
A team led by Changcheng Zhou in the UK Department of Pharmacology and Nutritional Sciences has discovered a likely pathway by which antiretroviral drugs effect liver disease.
In an editorial published in CNS Spectrums, UK Neurologist Jay Avasarala, MD, PhD, takes the research community to task for its lack of minority representation in Phase III clinical trials for drugs to treat Multiple Sclerosis (MS).
While summer may be a time for a break for some students, for others it is a time for to take advantage of less time in the classroom and more time spent exploring and learning in research laboratories throughout campus.
Joe Chappell in the College of Pharmacy is partnering with Space Tango to test whether sending plants to space increases their ability to produce healing properties.
In an article recently published in the Journal of the American Medical Association, Drs. Lofwall and Walsh studied the efficacy and safety of buprenorphine delivered as a weekly or monthly injection for moderate-to-severe opioid use disorder.
This strategic collaboration, which includes UK's Office of Technology Commercialization and a pharmacy researcher at UK, involves R&D for US WorldMeds’ investigational product, lofexidine.
